A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants
Clinical trial NCT02016066 · WITHDRAWN
Trial details
- NCT number
- NCT02016066
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.